ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Solomon Gard’s Questions/Answers

January 2, 1981

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009